Plunkett Research Online: ALK-Abello A/S

ALK-ABELLO A/S (AKABY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ALK-Abello A/S is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies. It develops drugs that targets the cause of allergy. The company’s allergy immunotherapy induces a protective immune response that provides a sustained reduction of a.....



ALK-Abello A/S
Ticker: AKABY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 45 45747576
Fax: 45 45748690
Address: Boge Alle 6-8
Horsholm, DK–2970 Denmark

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

Carsten HellmannCEO/Pres.
Flemming PedersenCFO/Exec. VP
See More
ALK-Abello A/S is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies. It develops drugs that targets the cause of allergy. The company’s allergy immunotherapy induces a protective immune response that provides a sustained reduction of a.....See More See More

Auditor: Deloitte Statsautoriseret Revisionspartnerselskab
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Ragwitek
Alutard SQ
AVANZ
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: